Whitestar Signature Pro System

Next-generation phaco system design improves stability, reduces energyLos Angeles ophthalmologist Mitchell Shultz, MD, shares some of his clinical experience with a next-generation phacoemulsification platform (Stellaris Elite, Bausch + Lomb). The new platform received 510(k) clearance from the FDA in April.
Phaco platform proving positive in physician’s practiceFeatures of a new phacoemulsification platform provide surgeons with improvements to outcomes, safety, and cost and time effectiveness.
AMO launches second phaco platform this yearThe availability of a new cataract surgery platform from Abbott Medical Optics (AMO) marks the second phacoemulsification system launched by the company in the United States this year.